Insider · CIK 0002016630
Matthew Paul Del Giudice
Files at MIRA (MIRA PHARMACEUTICALS, INC.), TELO (Telomir Pharmaceuticals, Inc.). First filing -, latest -.
Matthew Paul Del Giudice files SEC Form 4 as director at MIRA (MIRA PHARMACEUTICALS, INC.), and also at TELO (Telomir Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew Paul Del Giudice has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Stock Options (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 15, 2026 |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | AGrant or award Incentive Stock Options (right to buy)derivative | +25,000 | - | - | 25,000 | May 22, 2026 |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | DDisposition to issuer Incentive Stock Options (right to buy)derivative | -25,000 | - | - | 0 | May 22, 2026 |
| Dec 9, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Stock Options (right to buy)derivative | +25,000 | $0.00 | $0 | 75,000 | Dec 10, 2024 |
Questions about Matthew Paul Del Giudice
Answered from the filings on this page, as of the latest one.
Is Matthew Paul Del Giudice buying or selling?
Matthew Paul Del Giudice has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew Paul Del Giudice's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Paul Del Giudice has 0.
Where does Matthew Paul Del Giudice file Form 4?
Matthew Paul Del Giudice has filed Form 4 at MIRA (MIRA PHARMACEUTICALS, INC.); TELO (Telomir Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.